Endocrinology Medical News about polycystic ovary syndrome

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

3. Rapid correction of low vitamin D status in nursing home residents

4. 2008 Exclusive Survey—Earnings: Good news for primary care income

5. Medicare pay-for-reporting effort draws fire from frustrated doctors

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Use of antiandrogens as therapy for women with polycystic ovary syndrome
Fertility and Sterility, 08/14/06

Paolo Moghetti M.D., et al - Because androgen excess plays a fundamental role in symptoms and, it is likely, in pathogenesis of polycystic ovary syndrome, attenuation of hyperandrogenism appears to be of paramount importance in the therapy of this condition. Consistently, drugs inhibiting androgen receptor binding not only are an effective tool in hirsutism treatment but also show favorable effects on body composition and metabolic features of these women

<< Previous
Ovulation induction in women with polycystic ovary syndrome

Next >>
Pituitary actions of ligands of the TGF-ß family: activins and...